Financing of the acquisition of Human Med AG by PREMIUM Equity Partners

With a Frankfurt-based team led by Partner Thomas K. Schrell, business law firm Heuking Kühn Lüer Wojtek advised funds advised by PREMIUM Equity Partners on financing the acquisition of shares in Human Med AG. Heuking Kühn Lüer Wojtek comprehensively supported PREMIUM Equity Partners in drafting, structuring, negotiating, and implementing the entire financing documentation.

Schwerin-based Human Med AG is a leading global manufacturer of medical devices for patented waterjet-assisted liposuction (WAL) applied, among others, to the treatment of lipedema and in the regenerative medicine sector. Human Med employs a permanent staff of 56. In addition to device manufacturing, Human Med produces the related consumables and sterile disposable equipment in its own state-of-the-art clean room production facility built to the latest standards.

Established in 2011, PREMIUM Equity Partners is an investment firm focusing on strong niche companies in the Germany/Austria/Switzerland region with revenues between EUR 10 million and EUR 50 million. PREMIUM invests capital in growth financing, succession solutions, and spin-offs. In each of its investments, PREMIUM combines its many years of transaction and financing experience with the sector expertise of its industry partners. This is PREMIUM’s ninth corporate acquisition.

The investment by PREMIUM Mittelstand Fund II GmbH & Co. KG benefits from European Union financial support under the European Fund for Strategic Investments (“EFSI”). The purpose of the EFSI is to support the financing and implementation of economically viable investments in the European Union and to ensure improved access to finance.

Counsel to PREMIUM
Heuking Kühn Lüer Wojtek:
Thomas K. W. Schrell, LL.M. (Lead, Banking & Finance), Frankfurt
Anja Harms (Banking & Finance), Frankfurt